Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for difficult direct laryngoscopic exposure
IRCT20210712051865N1Phase 4Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of magnesium sulfate in difficult airway, sponsored by Shiraz University of Medical Sciences. Primary endpoint: laryngeal exposure. Started Sep 2021; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
difficult airway
Beyond the preview
Go deeper on IRCT20210712051865N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210712051865N1.